At Imost Arabia, we are pioneering the future of health diagnostics with our groundbreaking iMOST platform. Our team, a dynamic and multidisciplinary group of experts from industry, healthcare, and academia, excels in bio-engineering, nanotechnology, advanced imaging, artificial intelligence, machine learning, and medicine.

Imost Arabia was founded in 2013 by Dr. Stephen Y. Chou and Dr. Lin Chou. Dr. Stephen Y. Chou is one of the world’s leading nanotechnology experts, with deep experience in bioengineering, sensors, and clinical diagnostics. Lin Chou has been an internist for over 30 years.

iMOST platform represents a significant leap forward in digital health technology. Designed as an industry-first, it enables individuals to conduct self-evaluations for various diseases and health-related biomarkers—including cells, proteins, small molecules, and nucleic acids—using just a tiny drop of body fluid such as blood, saliva, urine, or sweat. Our technology delivers results within minutes, anytime and anywhere, and communicates them instantly to healthcare professionals.

The iMOST platform is not only fast, user-friendly, and cost-effective, but it also ensures the accuracy and reliability of clinical lab-quality test results. This innovative system is designed to be fault-tolerant, providing dependable outcomes even when the sample, device, process, or operation is less than perfect.

Imost Arabia is committed to transforming traditional, cumbersome, and costly lab testing with a convenient, mobile solution, making it the cornerstone of advanced, accessible digital health monitoring.